<DOC>
	<DOCNO>NCT02182960</DOCNO>
	<brief_summary>Pharmacokinetics ( relative bioavailability ) , safety tolerability</brief_summary>
	<brief_title>Bioavailability Ibuprofen Enantiomers Compared With Standard Brufen Sirup Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy male 21 50 year within +20 % normal weight ( Broca index ) Written informed consent Any finding medical examination laboratory test deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory ( especially bronchial asthma chronic obstructive pulmonary disease ) , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; =24 hour ) within least one month less ten halflives respective drug enrolment study Use drug might influence result trial within seven day prior administration trial Participation another trial investigational drug within two month prior start study Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke study day Alcohol abuse Drug abuse Blood donation ( &gt; 100 ml ) within four week prior administration Other disease abnormality clinical relevance Excessive physical activity within two week prior administration trial</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>